Patents by Inventor Naruyasu Komorita

Naruyasu Komorita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products
    Patent number: 6989401
    Abstract: The present invention relates to a novel sulfonic acid derivative of hydroxamic acid or a pharmacologically acceptable salt thereof. More particularly, the present invention relates to a sulfonic acid derivative of hydroxamic acid or a pharmacologically acceptable salt thereof, which is useful as an inhibitor of lipopolysaccharides (LPS). In addition, the present invention relates to a novel intermediate compound useful for the synthesis of this sulfonic acid derivative of hydroxamic acid.
    Type: Grant
    Filed: July 19, 2001
    Date of Patent: January 24, 2006
    Assignee: Mitsubishi Pharma Corporation
    Inventors: Kazuhiro Maeda, Shuji Sonda, Tadahiro Takemoto, Tomokazu Goto, Fujio Kobayashi, Masahiko Kajii, Naruyasu Komorita, Fumihiro Hirayama
  • Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products
    Publication number: 20030176486
    Abstract: The present invention relates to a novel sulfonic acid derivative of hydroxamic acid or a pharmacologically acceptable salt thereof. More particularly, the present invention relates to a sulfonic acid derivative of hydroxamic acid or a pharmacologically acceptable salt thereof, which is useful as an inhibitor of lipopolysaccharides (LPS). In addition, the present invention relates to a novel intermediate compound useful for the synthesis of this sulfonic acid derivative of hydroxamic acid.
    Type: Application
    Filed: February 14, 2003
    Publication date: September 18, 2003
    Inventors: Kazuhiro Maeda, Shuji Sonda, Tadahiro Takemoto, Tomokazu Goto, Fujio Kobayashi, Masahiko Kajii, Naruyasu Komorita, Fumihiro Hirayama
  • IgE antibody production inhibitors and autoimmune diseases inhibitors
    Patent number: 6528514
    Abstract: The present invention relates to an IgE antibody production inhibitor and an autoimmune disease suppressant containing a heterocyclic amide compound represented by the following general formula (1) or a pharmaceutically acceptable salt thereof as an active ingredient wherein R represents a hydrogen atom, alkyl, —CHO, —COOH, etc.; R5, R6 and R7 represent each hydrogen, alkyl, aryl, etc.; M represents a carbon atom or a nitrogen atom; Y represents aryl, etc.; and Z represents hydrogen, alkyl, aryl, etc.
    Type: Grant
    Filed: December 20, 2000
    Date of Patent: March 4, 2003
    Assignee: Welfide Corporation
    Inventors: Fujio Kobayashi, Shigeki Kuwahara, Naruyasu Komorita, Koji Naito, Teruaki Imada, Tsutomu Yoshikawa